Tuesday, August 6, 2013

New vaccine targets Hepatitis B eradication

August 5 - Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to stop the disease in its tracks and is currently seeking approval for its use in the United States and Europe. Elly Park reports.

See more....

No comments:

Post a Comment